← Open Payments lookup

DENNIS WESTIN: Open Payments

NPI 1992705388 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$210 in 10 payments from 7 companies in 2025. Trend: 2023 $260 · 2024 $216 · 2025 $210

Food & beverage: $210
CompanyPaymentsAmount
ABBVIE INC.2$44
Teva Pharmaceuticals USA, Inc.2$41
Takeda Pharmaceuticals U.S.A., Inc.2$34
Neurocrine BioSciences, Inc.1$26
E.R. Squibb & Sons, L.L.C.1$23
Almatica Pharma LLC1$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$18

Products named: VRAYLAR, AUSTEDO XR, TRINTELLIX, INGREZZA, COBENFY, LOREEV XR, CAPLYTA.

Industry payments across AZ — which companies pay providers there.